{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T02:06:21Z","timestamp":1721700381405},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"42","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Mucopolysaccharidosis type VI (MPS VI) or Maroteaux-Lamy syndrome is produced by the deficiency of the enzyme arylsulfatase B, responsible for the hydrolysis of N-acetyl-D-galactosamine, chondroitin sulfate, and dermatan sulfate.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>A 3-year-old male with Moroccan origins is the index case. He had healthy consanguineous parents and 4 healthy brothers and sisters. The patient showed a wide spectrum of symptoms including skeletal dysplasia and short stature with elevated glycosaminoglycans (GAGs) in urine.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses, interventions, and outcomes:<\/jats:title>\n            <jats:p>GAGs were quantified by spectrometry method with 1,9-dimethylen blue in 24-hour urine samples. The qualitative analysis of urine GAGs was obtained by thin-layer chromatography to determine the predominant presence of dermatan sulfate. The activities of both arylsulfatase B and beta-galactosidase as well as genetic studies were performed in dried blood spots. The genetic study was performed with deoxyribonucleic acid by massive sequencing a of lisosomal storage diseases. Results showed a new mutation c.263A\u200a&gt;\u200aC with the severe phenotype in homozygous in the patient. The familiar study of <jats:italic toggle=\"yes\">ARSB<\/jats:italic> and <jats:italic toggle=\"yes\">GLB1<\/jats:italic> genes presented some asymptomatic SNPs but with a discrete decrease in the activity of arylsulfatase B and beta-galactosidase. After an early detection by pediatricians, and both enzymatic and genetic confirmation, the patient had a good response to substitutive enzymatic treatment with galsulfase.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>Mucoplysaccharidosis type VI is an autosomal recessive rare disease characterized by a lysosomal storage disorder. Although a number of mutations have been already associated to the disease, we have found a new mutation located in the arylsulfatase B enzyme gene. We have described that this mutation is the ultimate cause of a severe presentation of the disease.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000012872","type":"journal-article","created":{"date-parts":[[2018,10,17]],"date-time":"2018-10-17T23:14:10Z","timestamp":1539818050000},"page":"e12872","source":"Crossref","is-referenced-by-count":2,"title":["Family study of a novel mutation of mucopolysaccharidosis type VI with a severe phenotype and good response to enzymatic replacement therapy"],"prefix":"10.1097","volume":"97","author":[{"given":"Myriam","family":"Ley-Martos","sequence":"first","affiliation":[{"name":"Pediatric Neurology and Rare Diseases Unit, Department of Pediatry, Hospital Universitario Puerta del Mar, C\u00e1diz"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan M.","family":"Guerrero","sequence":"additional","affiliation":[{"name":"Molecular Diagnosis and Rare Diseases Laboratory, Department of Clinical Chemistry, Hospital Universitario Virgen del Roc\u00edo and Instituto de Biomedicina de Sevilla (IBiS), Sevilla"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Lucas-Javato","sequence":"additional","affiliation":[{"name":"Molecular Diagnosis and Rare Diseases Laboratory, Department of Clinical Chemistry, Hospital Universitario Virgen del Roc\u00edo and Instituto de Biomedicina de Sevilla (IBiS), Sevilla"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Rem\u00f3n-Garc\u00eda","sequence":"additional","affiliation":[{"name":"Pneumology Unit, Department of Pediatry, Hospital Universitario Puerta del Mar, C\u00e1diz"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Ra\u00fal","family":"Garc\u00eda-Lozano","sequence":"additional","affiliation":[{"name":"Molecular Diagnosis Unit, Department of Clinical Immunology, Hospital Universitario Virgen del Roc\u00edo and Instituto de Biomedicina de Sevilla (IBiS), Sevilla"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Crist\u00f3bal","family":"Col\u00f3n","sequence":"additional","affiliation":[{"name":"Diagnosis and Treatment of Congenital Metabolic Diseases Unit, Department of Pediatry, Hospital Cl\u00ednico Universitario and Instituto de Investigacion en Salud (IDIS), Santiago de Compostela"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo","family":"Crujeiras","sequence":"additional","affiliation":[{"name":"Diagnosis and Treatment of Congenital Metabolic Diseases Unit, Department of Pediatry, Hospital Cl\u00ednico Universitario and Instituto de Investigacion en Salud (IDIS), Santiago de Compostela"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Rodrigues","sequence":"additional","affiliation":[{"name":"Diagnosis and Treatment of Congenital Metabolic Diseases Unit, Department of Pediatry, Hospital Cl\u00ednico Universitario and Instituto de Investigacion en Salud (IDIS), Santiago de Compostela"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro","family":"Pa\u00fal-S\u00e1nchez","sequence":"additional","affiliation":[{"name":"Department of Pediatry, Hospital Universitario, Ceuta, Spain."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hada C.","family":"Macher","sequence":"additional","affiliation":[{"name":"Molecular Diagnosis and Rare Diseases Laboratory, Department of Clinical Chemistry, Hospital Universitario Virgen del Roc\u00edo and Instituto de Biomedicina de Sevilla (IBiS), Sevilla"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230914","first-page":"1849","article-title":"A new dysostosis with urinary elimination of chondroitin sulfate B","volume":"71","author":"Maroteaux","year":"1963","journal-title":"Presse Med"},{"key":"R2-20230914","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000132048","article-title":"Assignment of the human arylsulfatase B gene, ARSB, to the chromosomal region 5p11-5qter","volume":"38","author":"Fidzianska","year":"1984","journal-title":"Cytogenet Cell Genet"},{"key":"R3-20230914","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/humu.1190","article-title":"Mucopolysaccharidosis type VI: structural and clinical repercussions of mutations in N-acetylgalactosamine-4-sulfatase","volume":"18","author":"Litjens","year":"2001","journal-title":"Hum Mutat"},{"key":"R4-20230914","first-page":"337","article-title":"Mucopolysaccharidosis VI (Maroteaux-Lamy disease)","volume":"25","author":"Spranger","year":"1987","journal-title":"Helv Paediatr Acta"},{"key":"R5-20230914","first-page":"215","article-title":"Hydrocephalus lumbar canal stenosis and Maroteaux-Lamy syndrome (mucopolysaccharidosis type 6). Report of a case","volume":"36","author":"Sheridan","year":"1992","journal-title":"J Neurosurg Sci"},{"key":"R6-20230914","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.ijporl.2005.01.017","article-title":"Otorhinolaryngological manifestations of the mucopolysaccharidoses","volume":"69","author":"Simmons","year":"2005","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"R7-20230914","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s10792-008-9213-7","article-title":"Reversed papilledema in an MPS VI patient with galsulfase (Naglazyme) therapy","volume":"29","author":"Koseoglu","year":"2009","journal-title":"Int Ophthalmol"},{"key":"R8-20230914","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0006-291X(88)80038-X","article-title":"Cloning, sequencing, and expression of cDNA for human beta-galactosidase","volume":"157","author":"Oshima","year":"1988","journal-title":"Biochem Biophys Res Commun"},{"key":"R10-20230914","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1542\/peds.2006-2184","article-title":"Management guidelines for mucopolysaccharidosis VI","volume":"120","author":"Giugliani","year":"2007","journal-title":"Pediatrics"},{"key":"R11-20230914","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ymgme.2017.03.008","article-title":"The effect of galsulfase enzyme replacement therapy on the growth of patients with mucopolysaccharidosis VI (Maroteaux-Lamy syndrome)","volume":"122","author":"Harmatz","year":"2005","journal-title":"Mol Genet Metab"},{"key":"R12-20230914","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.cccn.2004.10.009","article-title":"Development of an assay for the detection of mucopolysaccharidosis type VI patients using dried blood-spots","volume":"353","author":"Hein","year":"2005","journal-title":"Clin Chim Acta"},{"key":"R13-20230914","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0009-8981(71)90446-3","article-title":"Differential effect of chloride ions on (-galactosidase isoenzymes: a method for separate assay","volume":"32","author":"Ho","year":"1971","journal-title":"Clin Chim Acta"},{"key":"R14-20230914","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1399-0004.2009.01324.x","article-title":"Enzyme replacement therapy for mucopolysaccharidosis VI from 8 weeks of age: a sibling control study","volume":"77","author":"McGill","year":"2010","journal-title":"Clin Genet"},{"key":"R15-20230914","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.ymgme.2011.08.029","article-title":"Enzyme replacement therapy attenuates disease progression in two Japanese siblings with mucopolysaccharidosis type VI","volume":"104","author":"Furujo","year":"2011","journal-title":"Mol Genet Metab"},{"key":"R16-20230914","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s10545-012-9481-2","article-title":"Enzyme replacement therapy for mucopolysac- charidosis VI: long-term cardiac effects of galsulfase (Naglazyme () therapy","volume":"36","author":"Braunlin","year":"2013","journal-title":"J Inherit Metab Dis"},{"key":"R17-20230914","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/pd.2416","article-title":"Prenatal diagnosis of mucopolysaccharidosis VI by enzyme assay in a dried spot of fetal blood: a pioneering case report","volume":"30","author":"Burin","year":"2010","journal-title":"Prenat Diagn"},{"key":"R18-20230914","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1136\/adc.66.7_Spec_No.816","article-title":"Antenatal diagnosis of inborn errors of metabolism","volume":"66","author":"Cleary","year":"1991","journal-title":"Arch Dis Child"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00005792-201810190-00065","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T17:56:25Z","timestamp":1694714185000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201810190-00065"}},"subtitle":["Case report"],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":17,"journal-issue":{"issue":"42","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000012872","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10]]}}}